Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
In his monthly column, Editorial Board member Mina Makary, M.D., assistant professor of radiology at The Ohio State University Wexner Medical Center, takes on the topic of non-invasive virtual biopsy. Look for his blog later this week to see the case he lays out for why it’s a better, safer option for the future of cancer management.
For more of Makary’s blogs, click here.
When found early, thyroid cancer has a good prognosis, but it is typically diagnosed by needle biopsy. Recently published research reveals that combining photoacoustic and ultrasound images with artificial intelligence can lead to accurate diagnoses in a non-invasive way. Look for an article later this week that details the results of this study published in Cancer Research.
For more coverage of thyroid cancer and thyroid imaging, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
The outlook for most men with prostate cancer is good, but proper treatment planning is essential. In a column this week, Yashbir Mehta, M.D., radiology oncologist from UroPartners, explores the role that CT plays in improving accuracy and augmenting patient comfort during the treatment planning process. Look for the article in the coming days.
For more coverage prostate cancer, click here.
New Study Assesses Benefits of High-Resolution Photon-Counting for Computed Tomography Angiography
October 10th 2024Researchers found that ultra-high resolution photon-counting significantly enhanced visualization of small vessels and facilitated improved reduction of blooming artifacts for head and neck computed tomography angiography (CTA) scans.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.